ZA865097B - Phenyl ethers - Google Patents

Phenyl ethers

Info

Publication number
ZA865097B
ZA865097B ZA865097A ZA865097A ZA865097B ZA 865097 B ZA865097 B ZA 865097B ZA 865097 A ZA865097 A ZA 865097A ZA 865097 A ZA865097 A ZA 865097A ZA 865097 B ZA865097 B ZA 865097B
Authority
ZA
South Africa
Prior art keywords
phenyl ethers
ethers
phenyl
Prior art date
Application number
ZA865097A
Other languages
English (en)
Inventor
Brian Roy Holloway
Ralph Howe
Balbir Singh Rao
Donald Stribling
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of ZA865097B publication Critical patent/ZA865097B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
ZA865097A 1985-07-30 1986-07-08 Phenyl ethers ZA865097B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858519154A GB8519154D0 (en) 1985-07-30 1985-07-30 Aromatic ethers

Publications (1)

Publication Number Publication Date
ZA865097B true ZA865097B (en) 1987-03-25

Family

ID=10583042

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA865097A ZA865097B (en) 1985-07-30 1986-07-08 Phenyl ethers

Country Status (27)

Country Link
US (1) US4772631A (xx)
EP (1) EP0210849B1 (xx)
JP (2) JPH0651661B2 (xx)
KR (1) KR870001142A (xx)
CN (1) CN1014516B (xx)
AR (1) AR242176A1 (xx)
AT (1) ATE55980T1 (xx)
AU (1) AU603987B2 (xx)
CA (1) CA1283122C (xx)
CS (1) CS266593B2 (xx)
DD (1) DD251551A5 (xx)
DE (1) DE3673722D1 (xx)
DK (1) DK168761B1 (xx)
ES (1) ES2002720A6 (xx)
FI (1) FI88030C (xx)
GB (1) GB8519154D0 (xx)
GR (1) GR861994B (xx)
HU (1) HUT44757A (xx)
IE (1) IE60157B1 (xx)
IL (1) IL79447A0 (xx)
NO (1) NO170480C (xx)
NZ (1) NZ217011A (xx)
PH (1) PH22503A (xx)
PL (1) PL152320B1 (xx)
PT (1) PT83085B (xx)
SU (1) SU1632370A3 (xx)
ZA (1) ZA865097B (xx)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300290B1 (de) * 1987-07-21 1991-12-18 F. Hoffmann-La Roche Ag Phenoxypropanolamine
GB8801306D0 (en) * 1988-01-21 1988-02-17 Ici Plc Chemical compounds
GB8905336D0 (en) * 1989-03-08 1989-04-19 Ici Plc Chemical compounds
GB8910374D0 (en) * 1989-05-05 1989-06-21 Ici Plc Chemical compounds
KR920005952B1 (ko) * 1989-05-26 1992-07-25 이사무 이와이 오수정화조의 여과재 순환 정화장치
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds
GB8926083D0 (en) * 1989-11-17 1990-01-10 Ici Plc Therapeutic agents
GB9003185D0 (en) * 1990-02-13 1990-04-11 Ici Plc Pharmaceutical compositions
US5151439A (en) * 1990-05-04 1992-09-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5245053A (en) * 1990-05-04 1993-09-14 American Cyanamid Company Substituted 5-(2-(2-aryl-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxoles
US5061727A (en) 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5106867A (en) * 1990-05-04 1992-04-21 American Cyanamid Company Method of increasing lean meat in edible animals
GB9016655D0 (en) * 1990-07-30 1990-09-12 Ici Plc Therapeutic agents
US5502078A (en) * 1991-05-28 1996-03-26 Zeneca Limited Chemical compounds
GB9111426D0 (en) * 1991-05-28 1991-07-17 Ici Plc Chemical compounds
GB9111425D0 (en) * 1991-05-28 1991-07-17 Ici Plc Chemical compounds
GB9224740D0 (en) * 1992-11-26 1993-01-13 Ici Plc Therapeutic agents
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5488064A (en) * 1994-05-02 1996-01-30 Bristol-Myers Squibb Company Benzo 1,3 dioxole derivatives
US5491134A (en) * 1994-09-16 1996-02-13 Bristol-Myers Squibb Company Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US6075040A (en) 1996-09-05 2000-06-13 Eli Lilly And Company Selective β3 adrenergic agonists
US5770615A (en) * 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
ATE215369T1 (de) 1996-09-05 2002-04-15 Lilly Co Eli Carbazolanaloge als selektive beta3-adrenergische agonisten
CO5011072A1 (es) * 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
GB9812709D0 (en) * 1998-06-13 1998-08-12 Glaxo Group Ltd Chemical compounds
US6344481B1 (en) 1999-03-01 2002-02-05 Pfizer Inc. Thyromimetic antiobesity agents
US7709677B2 (en) * 2001-01-31 2010-05-04 Glaxosmithkline Llc Process of preparing arylethanoldiamines
GB0102407D0 (en) 2001-01-31 2001-03-14 Glaxo Group Ltd Process
US7504435B2 (en) * 2001-01-31 2009-03-17 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method for stimulating weight loss and/or for lowering triglycerides in patients
US7202222B2 (en) * 2003-01-06 2007-04-10 National Bioscience Corporation Methods for treatment of obesity and effective fat loss promotion
CA2679402A1 (en) * 2007-02-27 2008-09-04 The Arizona Board Of Regents On Behalf Of The University Of Arizona Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
US8476227B2 (en) 2010-01-22 2013-07-02 Ethicon Endo-Surgery, Inc. Methods of activating a melanocortin-4 receptor pathway in obese subjects
US9907767B2 (en) 2010-08-03 2018-03-06 Velicept Therapeutics, Inc. Pharmaceutical compositions and the treatment of overactive bladder
US9522129B2 (en) 2010-08-03 2016-12-20 Velicept Therapeutics, Inc. Pharmaceutical Combination
CA2866080C (en) * 2012-03-01 2021-01-19 University Of Cincinnati Ros-activated compounds as selective anti-cancer therapeutics
AU2015358378A1 (en) 2014-12-03 2017-06-29 Velicept Therapeutics, Inc. Compositions and methods of using modified release solabegron for lower urinary tract symptoms
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
PT3365321T (pt) 2015-10-23 2024-01-12 B3Ar Therapeutics Inc Zwiterião de solabegron e suas utilizações

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1957706C3 (de) * 1968-11-18 1978-06-29 Pfizer Corp., Colon (Panama) Kernsubstituierte 3-Phenoxy-l-phenoxyalkylamino-propan-2-ole und Arzneimittel auf deren Basis
GB1245148A (en) * 1968-11-18 1971-09-08 Pfizer Ltd Propanolamine derivatives
SE354851B (xx) * 1970-02-18 1973-03-26 Haessle Ab
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
CH632987A5 (en) * 1976-10-07 1982-11-15 Haessle Ab Process for preparing novel amines
SE416545B (sv) * 1976-10-07 1981-01-19 Haessle Ab Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat
DE2965655D1 (en) * 1978-06-28 1983-07-21 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
SE7807408L (sv) * 1978-06-30 1979-12-31 Haessle Ab Hjertaktiva foreningar
EP0023385B1 (en) * 1979-06-16 1982-12-15 Beecham Group Plc Ethanamine derivatives, their preparation and use in pharmaceutical compositions
ATE2265T1 (de) * 1979-10-25 1983-02-15 Beecham Group Plc Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
IL65541A0 (en) * 1981-05-06 1982-07-30 Haessle Ab Alkylamino-2-propanols,process for their preparation and pharmaceutical preparations containing same
GB8415377D0 (en) * 1984-06-15 1984-07-18 Beecham Group Plc Compounds
GB8510146D0 (en) * 1985-04-20 1985-05-30 Smith Kline French Lab Chemical compounds & processes

Also Published As

Publication number Publication date
IL79447A0 (en) 1986-10-31
PL260759A1 (en) 1988-09-15
FI862896A (fi) 1987-01-31
PL152320B1 (en) 1990-12-31
AR242176A1 (es) 1993-03-31
CN1014516B (zh) 1991-10-30
DK168761B1 (da) 1994-06-06
KR870001142A (ko) 1987-03-11
FI862896A0 (fi) 1986-07-09
CS573586A2 (en) 1989-04-14
ATE55980T1 (de) 1990-09-15
FI88030B (fi) 1992-12-15
CS266593B2 (en) 1990-01-12
DD251551A5 (de) 1987-11-18
GB8519154D0 (en) 1985-09-04
EP0210849B1 (en) 1990-08-29
DK359986A (da) 1987-01-31
NO170480B (no) 1992-07-13
AU6002986A (en) 1987-02-05
SU1632370A3 (ru) 1991-02-28
ES2002720A6 (es) 1988-10-01
IE60157B1 (en) 1994-06-15
JPH06340597A (ja) 1994-12-13
CA1283122C (en) 1991-04-16
CN86105400A (zh) 1987-03-11
GR861994B (en) 1986-11-26
NO863061L (no) 1987-02-02
DK359986D0 (da) 1986-07-29
EP0210849A1 (en) 1987-02-04
IE861827L (en) 1987-01-30
NZ217011A (en) 1990-02-26
JPH0651661B2 (ja) 1994-07-06
HUT44757A (en) 1988-04-28
US4772631A (en) 1988-09-20
AU603987B2 (en) 1990-12-06
JPH0819062B2 (ja) 1996-02-28
DE3673722D1 (en) 1990-10-04
JPS6277357A (ja) 1987-04-09
NO863061D0 (no) 1986-07-29
PH22503A (en) 1988-09-12
PT83085A (en) 1986-08-01
NO170480C (no) 1992-10-21
PT83085B (pt) 1989-01-30
FI88030C (fi) 1993-03-25

Similar Documents

Publication Publication Date Title
IL79447A0 (en) Phenyl ethers
GB2178739B (en) Insecticidal ethers
GB8509348D0 (en) Ethers
NZ215263A (en) Silylenol ethers
GB8609821D0 (en) Cyclopentyl ethers
GB8615743D0 (en) 5 6-epoxy-7-oxabicycloheptane substituted ethers
GB8616586D0 (en) Phenyl ethers
GB2172279B (en) Pyroeletric ceramics
ZA853550B (en) Azolylvinyl ethers
ZA863194B (en) Substituted azolylmethyl ethers
GB8525456D0 (en) Arylglycidyl ethers
GB8511893D0 (en) Ethers
PH22761A (en) Novel 4-acylresorcinol ethers
IE843342L (en) (3-hydroxy-4-alkoxy)phenyl esters- sweeteners
GB8900385D0 (en) Insecticidal ethers
DE3573117D1 (en) Resorcinol ethers
IE843202L (en) Phenyl alkyl ethers
IE851902L (en) Fragrant ethers
IE851167L (en) Cyclic azovinyl ethers
IE851294L (en) Resorcinol ethers
IE852807L (en) Resorcinol ethers
ZA858772B (en) Further novel resorcinol ethers
IL76995A0 (en) Further novel resorcinol ethers
GB8527662D0 (en) Cylic ethers
GB8519477D0 (en) Slide mount